Temozolomide Capsule
Product Images NDC 73043-014

Product Visual Gallery

This gallery contains 8 technical images submitted to the FDA as part of the official labeling for Temozolomide (NDC 73043-014). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Devatis, Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Temo-100mg-5s (Temo 100mg 5s)

FDA Label Image

Temo-140mg-5s (Temo 140mg 5s)

FDA Label Image

Temo-180mg-5s (Temo 180mg 5s)

FDA Label Image

Temo-20mg-5s (Temo 20mg 5s)

FDA Label Image

Temo-250mg-5s (Temo 250mg 5s)

FDA Label Image

Temo-5mg-5s (Temo 5mg 5s)

FDA Label Image

Kaplan-meier Curves (Temo Fig2)

This text contains information about the overall survival rates for a population under investigation. The hazard ratio (HR) is calculated to be 0.63 with a 95% Confidence Interval (CI) of 0.52 to 0.75. The log-rank P-value is reported to be less than 0.0001. The time from randomization is indicated in months ranging from 12 to 28.*

FDA Label Image

Chemical-structure (Temo Structure)

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.